K
Kenneth W. Hill
Researcher at Agilent Technologies
Publications - 5
Citations - 77
Kenneth W. Hill is an academic researcher from Agilent Technologies. The author has contributed to research in topics: Derivative (chemistry) & Aryl. The author has an hindex of 3, co-authored 5 publications receiving 73 citations.
Papers
More filters
Journal ArticleDOI
Streamlined Process for the Chemical Synthesis of RNA Using 2′-O-Thionocarbamate-Protected Nucleoside Phosphoramidites in the Solid Phase
Douglas J. Dellinger,Zoltan Timar,Joel Myerson,Agnieszka B. Sierzchala,John O. Turner,Fernando Ferreira,Zoltán Kupihár,Geraldine F Dellinger,Kenneth W. Hill,James A. Powell,Jeffrey R. Sampson,Marvin H. Caruthers +11 more
TL;DR: An improved method was developed utilizing a streamlined method for the preparation of phosphoramidite monomers and a single-step deprotection of the resulting oligoribonucleotide product using 1,2-diamines under anhydrous conditions and it was demonstrated that the chemical synthesis of RNA can be as simple and robust as thechemical synthesis of DNA.
Patent
Retro diels alder reaction as a cleavable linker in dna/rna applications
TL;DR: In this article, an approach for reversibly conjugating an oligonucleotide was proposed, which includes obtaining an oligoneucleotide labeled with a diene moiety and a target entity labeled with dienophile moiety, and heating the oligoneuclidean to a solution at a first temperature to effect Diels Alder reaction to produce a conjugate.
Patent
Compositions and Methods for Conjugating Oligonucleotides
Kenneth W. Hill,Victor R. Mokler +1 more
TL;DR: An oligonucleotide derivative having the structure of formula (A) and methods for preparing the oligon nucleotide derivative are disclosed in this paper, where an amino or thiol group is added to the first oligonotide derivative.
Patent
Preparation of long synthetic oligonucleotides by squarate conjugation chemistry
TL;DR: In this article, the authors provide methods of conjugating oligonucleotides using a squarate reagent to produce an activated first oligonotide, and binding the first and second oligon nucleosides to a splint splint.
Patent
Method for conjugating oligonucleotides
Kenneth W. Hill,Victor R. Mokler +1 more
TL;DR: In this paper, an oligonucleotide derivative having the structure of formula (A) and methods for preparing the oligon nucleotide derivative are disclosed, wherein R3 is a first oligonotide; R1 is selected from the group consisting of alkyl, cycloalkyl, aryl, heterocyclyl, and heteroaryl, a polyethylene glycol, a peptide, a protein, polysaccharide, and a second oligoneotide.